Peter Elliott

Stocks Buzz: The Western Union Company (WU), HP Inc. (HPQ), Morgan Stanley (MS)

The Western Union Company (WU) continued its downward trend with the stock declining -3.3% or $-0.72 to close the day at $21.13 on light trading volume of 15.15M shares, compared to its three month average trading volume of 4.05M. The Englewood Colorado 80112 based company has been outperforming the credit services group over the past 52 weeks, with the stock gaining 32.24%, compared to the industry which has advanced 25.6% over the same period. With RSI of 38.76, the stock should still continue to rise and get closer to its one year target estimate of $19.65, making it a hold for now.

The Western Union Company provides money movement and payment services worldwide. The company operates in three segments: Consumer-to-Consumer, Consumer-to-Business, and Business Solutions. The Consumer-to-Consumer segment offers money transfer services. This segment provides various options for sending funds, including walk-in and online money transfer, as well as account based money transfer services through a network of third-party agents using multi-currency and real-time money transfer processing systems. The Consumer-to-Business segment offers options to make one-time or recurring payments from consumers to businesses and other organizations, including utilities, auto finance companies, mortgage servicers, financial service providers, government agencies, and other businesses. It also provides various products, which provide consumers choices as to the payment channel and method of payment, including Speedpay, Pago Fácil, and Western Union Payments. This segment offers its services primarily through the phone and Online, as well as through its agent networks and selected company-owned locations. The Business Solutions segment facilitates payment and foreign exchange solutions, primarily cross-border and cross-currency transactions for small and medium size enterprises and other organizations, as well as for individuals. This segment provides its services through the phone, partner channels, and the Internet. As of December 31, 2015, the company had a network of approximately 500,000 agent locations in approximately 200 countries and territories. The Western Union Company was incorporated in 2006 and is headquartered in Englewood, Colorado.

HP Inc. (HPQ) grew with the stock adding 1.92% or $0.28 to close at $14.86 on active trading volume of 15.08M compared its three months average trading volume of 12.03M. The Palo Alto California 94304 based company operating under the Diversified Computer Systems industry has been trending up for the last 52 weeks, with the shares price now 61.58% up for the period and up by 0.13% so far this year. With price target of $16.1 and a 73.19% rebound from 52-week low, HP Inc. has plenty of upside potential, making it a hold with a view buy.

HP Inc. provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses, as well as to the government, health, and education sectors worldwide. It operates through Personal Systems and Printing segments. The Personal Systems segment offers commercial personal computers (PCs), consumer PCs, workstations, thin clients, commercial tablets and mobility devices, retail point-of-sale systems, displays and other related accessories, software, support, and services for the commercial and consumer markets. The Printing segment provides consumer and commercial printer hardware, supplies, media, solutions, and services, as well as scanning devices; and laserjet and enterprise, inkjet and printing, graphics, and 3D printing solutions. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.

Morgan Stanley (MS) failed to extend gains with the stock declining -0.96% or $-0.41 to close the day at $42.45 on higher than average trading volume of 15.04M shares, compared to its three month average trading volume of 12.29M. The New York New York 10036 based company has been outperforming the investment brokerage – national companies by 31.8592% for last three months and its recent gains have pushed the stock slightly up 0.47% YTD, versus the investment brokerage – national industry which is up 0.9% for the same period. The RSI of 48.53 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. The company’s Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides sales and trading services, such as sales, financing, and market-making services in equity securities and fixed income products, including foreign exchange and commodities, as well as prime brokerage services; and corporate lending services, credit products, and investments and research services. Its Wealth Management segment offers various financial services and solutions covering brokerage and investment advisory services, market-making services in fixed income securities, financial and wealth planning services, annuity and insurance products, credit and other lending products, and banking and retirement plan services to individual investors, small-to-medium sized businesses, and institutions. The company’s Investment Management segment provides various investment strategies and products comprising asset management, including equity, fixed income, liquidity, alternatives, and managed futures products. This segment is also involved in merchant banking and real estate investing businesses. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.

 

Stocks To Watch: Xerox Corporation (XRX), Starbucks Corporation (SBUX), Altria Group, Inc. (MO)

Xerox Corporation (XRX) traded within a range of $6.91 to $7.01 after opening the day at $7.01. The company has seen its stock increase in value by 20.7% so far this year. The stock was down close to -1.14% on light volume in last trading session and closed at $6.94 per share. After the recent fall, the stock is currently holding -5.15% below its 52 week high of $11.39 and 28.33% above its 12-month low of $6.46. The shares are up by over 9.43% in the last three months, and the RSI indicator value of 62.03 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Xerox Corporation provides business process and document management solutions worldwide. Its Services segment offers business process outsourcing services, such as customer care, transaction processing, finance and accounting, human resources, communication and marketing, and consulting and analytics services, as well as services in the areas of healthcare, transportation, financial services, retail, and telecommunications areas. This segment also provides document outsourcing services comprising managed print services, including workflow automation and centralized print services. The company’s Document Technology segment offers desktop monochrome and color printers, multifunction printers, copiers, digital printing presses, and light production devices; and production printing and publishing systems for the graphic communications marketplace and large enterprises. Its Other segment sells paper, wide-format systems, global imaging systems network integration solutions, and electronic presentation systems. The company sells its products and services directly to its customers; and through its sales force, as well as through a network of independent agents, dealers, value-added resellers, systems integrators, and the Web. Xerox Corporation was founded in 1906 and is headquartered in Norwalk, Connecticut.

Starbucks Corporation (SBUX) failed to extend gains with the stock declining -0.96% or $-0.56 to close the day at $57.89 on light trading volume of 7.84M shares, compared to its three month average trading volume of 8.83M. The Seattle Washington 98134 based company has been outperforming the specialty eateries group over the past 52 weeks, with the stock gaining 3.23%, compared to the industry which has advanced 5.59% over the same period. With RSI of 55.89, the stock should still continue to rise and get closer to its one year target estimate of $64.46, making it a hold for now.

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; China/Asia Pacific; Europe, Middle East, and Africa; and Channel Development. Its stores offer coffee and tea beverages, packaged roasted whole bean and ground coffees, single-serve and ready-to-drink coffee and tea products, juices, and bottled water; an assortment of fresh food and snack offerings; and various food products, such as pastries, breakfast sandwiches, and lunch items, as well as beverage-making equipment and accessories. The company also licenses its trademarks through licensed stores, and grocery and national foodservice accounts. It offers its products under the Starbucks, Teavana, Tazo, Seattle’s Best Coffee, Evolution Fresh, La Boulange, Ethos, Frappuccino, Starbucks Doubleshot, Starbucks Refreshers, and Starbucks VIA brand names. As of November 3, 2016, the company operated 25,085 stores. Starbucks Corporation was founded in 1971 and is based in Seattle, Washington.

Altria Group, Inc. (MO) gained $0.39 to close the day at a new closing price of $69.55, a 0.56% increase in value from its previous closing price that moved the stock 28.42% above its 52 week low of $56.76. A total of 7.83M shares exchanged hands during the day compared with its three month average trading volume of 6.84M. The stock, which fluctuated between $69.01 and $69.6 during the day, currently situated 0.51% above its 52 week high. The stock is up by 4.69% in the past one month and up by 12% over the past three months. With a one year target estimate of $69 and RSI of 75.74, the stock still has upside potential, making it a sell for now.

Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen and Skoal, Red Seal and Husky, and Marlboro Snus brand names. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle, Columbia Crest, and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in aircraft, railcar, electric power, real estate, and manufacturing industries. The company sells its tobacco products primarily to wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. Altria Group, Inc. was founded in 1919 and is headquartered in Richmond, Virginia.

 

Stocks In Queue: Abbott Laboratories (ABT), U.S. Bancorp (USB), Mast Therapeutics, Inc. (MSTX)

Abbott Laboratories (ABT) fell -0.88% during last trading as the stock lost $-0.36 to finish the day at $40.4 with about 7.16M shares changing hands, compared to its three month average trading volume of 9.13M. The $69.38B market cap company, which fluctuated between $40.24 and $40.73 during the day, currently situated 15.06% above its 52 week low of $36 and -10.64% away from its one year high of $45.79. The RSI of 57.71 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière’s disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company’s Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. In addition, it develops cardiovascular medical devices. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company has strategic alliance with Fonterra. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

U.S. Bancorp (USB) gained $0.17 to close the day at a new closing price of $50.73, a 0.34% increase in value from its previous closing price that moved the stock 40.29% above its 52 week low of $37.07. A total of 7.13M shares exchanged hands during the day compared with its three month average trading volume of 7.65M. The stock, which fluctuated between $50.42 and $50.98 during the day, currently situated -3.18% below its 52 week high. The stock is down by -1.42% in the past one month and up by 18.58% over the past three months. With a one year target estimate of $53.5 and RSI of 47.73, the stock still has upside potential, making it a hold for now.

U.S. Bancorp, a financial services holding company, provides a range of financial services in the United States. It offers depository services, which include checking accounts, savings accounts, and time certificate contracts; and lending services, such as traditional credit products, as well as credit card services, leasing financing, import/export trade, asset-backed lending, agricultural finance, and other products. The company also provides ancillary services, including capital markets, treasury management, and receivable lock-box collection services to corporate customers; and a range of asset management and fiduciary services for individuals, estates, foundations, business corporations, and charitable organizations. In addition, it offers investment and insurance products to the company’s customers principally within its markets, as well as fund administration services to a range of mutual and other funds. Further, the company provides corporate and purchasing card, and corporate trust services; and merchant processing services, as well as offers cash and investment management, ATM processing, mortgage banking, and brokerage and leasing services. It serves individuals, businesses, institutional organizations, governmental entities, and other financial institutions. The company offers its services through a network of 3,133 banking offices primarily in the Midwest and West regions of the United States; and a network of 4,936 ATMs, as well as through on-line services and over mobile devices. U.S. Bancorp was founded in 1863 and is headquartered in Minneapolis, Minnesota.

Mast Therapeutics, Inc. (MSTX) had a light trading with around 7.05M shares changing hands compared to its three month average trading volume of 9.28M. The stock traded between $0.125 and $0.136 before closing at the price of $0.13 with -5.54% change on the day. The San Diego California 92130 based company is currently trading 82.86% above its 52 week low of $0.07 and -81.97% below its 52 week high of $0.71. Both the RSI indicator and target price of 56.3 and $2.75 respectively, lead us to believe that it should be put on hold over the coming weeks.

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of heart failure with preserved ejection fraction. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

 

3 Trending Stocks: Norfolk Southern Corporation (NSC), Office Depot, Inc. (ODP), Biocept, Inc. (BIOC)

Norfolk Southern Corporation (NSC) continued its upward trend with the stock climbing 4.05% or $4.45 to close the day at $114.42 on active trading volume of 5.85M shares, compared to its three month average trading volume of 1.9M. The Norfolk Virginia 23510 based company has been outperforming the railroads group over the past 52 weeks, with the stock gaining 65.43%, compared to the industry which has advanced 13.02% over the same period. With RSI of 65.77, the stock should still continue to rise and get closer to its one year target estimate of $107.5, making it a hold for now.

Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods. It also transports overseas freight through various Atlantic and Gulf Coast ports; provides logistics services; and operates scheduled passenger trains. In addition, the company engages in the acquisition, leasing, and management of coal, oil, gas, and minerals; development of commercial real estate; telecommunications; and leasing or sale of rail property and equipment. As of March 1, 2016, it operated approximately 20,000 miles of road in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.

Office Depot, Inc. (ODP) fell -1.76% during last trading as the stock lost $-0.08 to finish the day at $4.46 with about 5.85M shares changing hands, compared to its three month average trading volume of 7.8M. The $2.34B market cap company, currently situated 48.98% above its 52 week low of $3.01 and -42.91% away from its one year high of $7.91. The RSI of 41.56 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Office Depot, Inc., together with its subsidiaries, supplies office products and services. It operates in three segments: North American Retail, North American Business Solutions, and International. The company sells office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture. It also offers copy and print services. The company sells its products and services to consumers and businesses through office supply stores, a contract sales force, Internet sites, an outbound telephone account management sales force, direct marketing catalogs, and call centers, as well as participates under licensing and merchandise arrangements in Latin America, Europe, Israel, and Japan. As of December 26, 2015, it operated 1,564 stores in the United States, including Puerto Rico and the U.S. Virgin Islands; and 147 stores in France, South Korea, Sweden, New Zealand, and Australia. The company offers its products under various labels, including Office Depot, OfficeMax, Foray, Ativa, TUL, Realspace, WorkPro, Brenton Studio, Highmark, Grand & Toy, and Viking Office Products. Office Depot, Inc. was founded in 1986 and is headquartered in Boca Raton, Florida.

Biocept, Inc. (BIOC) saw its value increase by 9.27% as the stock gained $0.14 to finish the day at a closing price of $1.65. The stock was higher in trading and has fluctuated between $0.74-$5.64 per share for the past year. The shares are up by 83.33% in the past three months and up by 166.13% over the past six months. It is currently trading 37.79% above its 20 day moving average and 66.38% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 57.65. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as breast cancer, lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.

 

Stocks in the Spotlight: Johnson & Johnson (JNJ), SLM Corporation (SLM), Oasis Petroleum Inc. (OAS)

Johnson & Johnson (JNJ) had a light trading with around 5.51M shares changing hands compared to its three month average trading volume of 7.05M. The stock traded between $113.92 and $114.9 before closing at the price of $114.2 with -0.44% change on the day. The New Brunswick New Jersey 08933 based company is currently trading 24.55% above its 52 week low of $94.28 and -8.18% below its 52 week high of $126.07. Both the RSI indicator and target price of 41.04 and $125.16 respectively, lead us to believe that it should be put on hold over the coming weeks.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

SLM Corporation (SLM) continued its upward trend with the stock climbing 2.81% or $0.31 to close the day at $11.35 on active trading volume of 5.49M shares, compared to its three month average trading volume of 4.43M. The Newark Delaware 19713 based company has been outperforming the credit services group over the past 52 weeks, with the stock gaining 109.8%, compared to the industry which has advanced 25.6% over the same period. With RSI of 58.41, the stock should still continue to rise and get closer to its one year target estimate of $12.65, making it a hold for now.

SLM Corporation, together with its subsidiaries, operates as a saving, planning, and paying for education company in the United States. It offers private education loans to students and their families. The company also provides banking products, such as certificates of deposits, money market deposit accounts, and high yield savings accounts; and a consumer savings network that offers financial rewards on everyday purchases to help families save for college. SLM Corporation was founded in 1972 and is headquartered in Newark, Delaware.

Oasis Petroleum Inc. (OAS) shares were down in last trading by -0.48% to $14.39. It experienced lighter than average volume on day. The stock decreased in value by almost -6.68% over the past week and fell -9.04% in the past month. It is currently trading 0.59% above its 50 day moving average and 33.14% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -15.75% decrease in value from its one year high of $17.08. The RSI indicator value of 44.16, lead us to believe that it is a hold for now.

Oasis Petroleum Inc., an independent exploration and production company, focuses on the acquisition and development of unconventional oil and natural gas resources in the North Dakota and Montana regions of the Williston Basin. Its principal projects are located in West Williston and East Nesson. As of December 31, 2015, the company had 484,745 net leasehold acres in the Williston Basin; and approximately 218.2 million barrels of oil equivalent of estimated net proved reserves. Oasis Petroleum Inc. sells its oil and natural gas to refiners, marketers, and other purchasers that have access to pipeline and rail facilities. The company was founded in 2007 and is headquartered in Houston, Texas.

 

Stocks To Track: Colony NorthStar, Inc. (CLNS), The Walt Disney Company (DIS), Superior Energy Services, Inc. (SPN)

Colony NorthStar, Inc. (CLNS) fell -1.28% during last trading as the stock lost $-0.18 to finish the day at $13.92 with about 5.36M shares changing hands, compared to its three month average trading volume of 3.89M. The $2.59B market cap company, which fluctuated between $13.79 and $14.05 during the day, currently situated 69.25% above its 52 week low of $9.17 and -7.01% away from its one year high of $16.08. The RSI of 46.61 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The Walt Disney Company (DIS) dropped $-0.88 to close the day at a new closing price of $107.28, a -0.81% decrease in value from its previous closing price that moved the stock 26.25% above its 52 week low of $86.25. A total of 5.35M shares exchanged hands during the day compared with its three month average trading volume of 8.4M. The stock, which fluctuated between $107.08 and $108.01 during the day, currently situated -2.02% below its 52 week high. The stock is up by 3.24% in the past one month and up by 18.58% over the past three months. With a one year target estimate of $109.59 and RSI of 58.08, the stock still has upside potential, making it a hold for now.

The Walt Disney Company, together with its subsidiaries, operates as an entertainment company worldwide. The company’s Media Networks segment operates cable programming services, including the ESPN, Disney channels, and Freeform networks; broadcast businesses, which include the ABC TV Network and eight owned television stations; radio businesses consisting of the ESPN Radio Network; and the Radio Disney network. It also produces and sells original live-action and animated television programming to first-run syndication and other television markets, as well as subscription video on demand services and in home entertainment formats, such as DVD, Blu-Ray, and iTunes. Its Parks and Resorts segment owns and operates the Walt Disney World Resort in Florida and the Disneyland Resort in California. This segment also operates Disney Resort & Spa in Hawaii, Disney Vacation Club, Disney Cruise Line, and Adventures by Disney; and manages Disneyland Paris, Hong Kong Disneyland Resort, and Shanghai Disney Resort, as well as licenses its intellectual property to a third party for the operations of the Tokyo Disney Resort in Japan. The company’s Studio Entertainment segment produces and acquires live-action and animated motion pictures for distribution in the theatrical, home entertainment, and television markets primarily under the Walt Disney Pictures, Pixar, Marvel, Lucasfilm, and Touchstone banners. This segment also produces stage plays and musical recordings; licenses and produces live entertainment events; and provides visual and audio effects, and other post-production services. Its Consumer Products & Interactive Media segment licenses its trade names, characters, and visual and literary properties; develops and publishes games for mobile platforms; and sells its products through The Disney Store, DisneyStore.com, and MarvelStore.com, as well as directly to retailers. The company was founded in 1923 and is based in Burbank, California.

Superior Energy Services, Inc. (SPN) had a active trading with around 5.26M shares changing hands compared to its three month average trading volume of 3.4M. The stock traded between $17.83 and $18.18 before closing at the price of $18.01 with -0.11% change on the day. The Houston Texas 77002 based company is currently trading 118.33% above its 52 week low of $8.25 and -9.18% below its 52 week high of $19.83. Both the RSI indicator and target price of 54.43 and $19.98 respectively, lead us to believe that it should be put on hold over the coming weeks.

Superior Energy Services, Inc. provides specialized oilfield services and equipment to crude oil and natural gas exploration and production companies in the United States, the Gulf of Mexico, and internationally. It operates through four segments: Drilling Products and Services; Onshore Completion and Workover Services; Production Services; and Technical Solutions. The Drilling Products and Services segment rents tubulars, including primary drill pipe strings, tubing landing strings, completion tubulars, and associated accessories; and manufactures and rents bottom hole tools, such as stabilizers, non-magnetic drill collars, and hole openers, as well as rents temporary onshore and offshore accommodation modules and accessories. The Onshore Completion and Workover Services segment offers pressure pumping services comprising hydraulic fracturing and high pressure pumping services used to complete and stimulate production in new oil and gas wells; fluid management services used to obtain, move, store, and dispose of fluids that are involved in the exploration, development, and production of oil and gas reservoirs; and workover services consisting of installations, completions, and sidetracking of wells, as well as support for perforating operations. The Production Services segment provides intervention services, including coiled tubing, cased hole and mechanical wireline, hydraulic workover and snubbing, production testing and optimization, and remedial pumping services. The Technical Solutions segment offers pressure control services; completion tools and services, such as sand control systems, well screens and filters, and surface-controlled sub surface safety valves; and offshore well decommissioning services, including plugging and abandoning wells at the end of their economic life, and dismantling and removing associated infrastructure. Superior Energy Services, Inc. was founded in 1991 and is headquartered in Houston, Texas.

 

Stocks in Review: Kohl’s Corporation (KSS), Celgene Corporation (CELG), Activision Blizzard, Inc. (ATVI)

Kohl’s Corporation (KSS) traded within a range of $40.07 to $41.37 after opening the day at $41.22. The company has seen its stock decrease in value by -18.53% so far this year. The stock was down close to -2.38% on active volume in last trading session and closed at $40.23 per share. After the recent fall, the stock is currently holding -32.58% below its 52 week high of $59.67 and 22.86% above its 12-month low of $33.87. The shares are down by over -5.67% in the last three months, and the RSI indicator value of 26.9 is bullish. They are not pointing to a rebound in the stock. We should get in as it looks to have found a bottom.

Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers. The company also sells its products online through Website Kohls.com. As of January 30, 2016, it operated 1,164 department stores in 49 states. Kohl’s Corporation was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.

Celgene Corporation (CELG) failed to extend gains with the stock declining -1.39% or $-1.6 to close the day at $113.62 on light trading volume of 4.7M shares, compared to its three month average trading volume of 4.94M. The Summit New Jersey 07901 based company has been outperforming the biotechnology group over the past 52 weeks, with the stock gaining 5.7%, compared to the industry which has advanced 1.71% over the same period. With RSI of 36.75, the stock should still continue to rise and get closer to its one year target estimate of $138.79, making it a hold for now.

Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Behçet’s disease, atopic dermatitis, and ulcerative colitis. The company’s products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN products. Its clinical stage products include OTEZLA for the treatment of various immune-inflammatory diseases; sotatercept for the treatment of renal anemia, beta-thalassemia and MDS; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; PDA-002 for the treat diabetic foot ulcers and peripheral neuropathy; and PNK-007 for hematological malignancies treatment. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; TriNetX, Inc.; Triphase Accelerator Corporation; Nurix Inc.; Abbott; Sage Bionetworks; and PharmAkea Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey.

Activision Blizzard, Inc. (ATVI) dropped $-0.22 to close the day at a new closing price of $38.86, a -0.56% decrease in value from its previous closing price that moved the stock 47.89% above its 52 week low of $26.49. A total of 4.61M shares exchanged hands during the day compared with its three month average trading volume of 8.69M. The stock, currently situated -14.69% below its 52 week high. The stock is up by 6.55% in the past one month and down by -12.04% over the past three months. With a one year target estimate of $48.52 and RSI of 58.36, the stock still has upside potential, making it a hold for now.

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games. The company operates through two segments, Activision Publishing, Inc. and Blizzard Entertainment, Inc. The company develops, publishes, and sells interactive software products and content through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes subscription-based massively multiplayer online role-playing games; and strategy and role-playing games. In addition, the company maintains a proprietary online gaming service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it engages in creating original film and television content; and provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases in the United States, Canada, Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, the Netherlands, Australia, South Korea, China, and internationally. Activision Blizzard, Inc. is headquartered in Santa Monica, California.

 

Worth Watching Stocks: Sprouts Farmers Market, Inc. (SFM), Under Armour, Inc. (UAA), VCA Inc. (WOOF)

Sprouts Farmers Market, Inc. (SFM) saw its value decrease by -2.38% as the stock dropped $-0.48 to finish the day at a closing price of $19.72. The stock was higher in trading and has fluctuated between $18.7-$30 per share for the past year. The shares are down by -7.5% in the past three months and down by -13.58% over the past six months. It is currently trading 0.01% above its 20 day moving average and -3.68% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $24.13 a share over the next twelve months. The current relative strength index (RSI) reading is 44.79.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company’s retail stores offer fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items, beer and wine, and dairy alternatives. As of November 3, 2016, it operated 252 stores in 13 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

Under Armour, Inc. (UAA) shares were down in last trading by -0.51% to $29.2. It experienced lighter than average volume on day. The stock decreased in value by almost -4.42% over the past week and fell -3.92% in the past month. It is currently trading -5.14% below its 50 day moving average and -21.7% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -39.1% decrease in value from its one year high of $47.95. The RSI indicator value of 35.15, lead us to believe that it is a hold for now.

Under Armour, Inc. together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot, cold, and in between the extremes. It provides various footwear products, including football, baseball, lacrosse, softball and soccer cleats, slides, performance training, running, basketball, and outdoor footwear. The company also offers accessories, which include headwear, bags, and gloves; and digital fitness platform licenses and subscriptions, as well as digital advertising, as well as licenses its brands. It primarily provides its products under the UA Logo, UNDER ARMOUR, UA, ARMOUR, HEATGEAR, COLDGEAR, ALLSEASONGEAR, PROTECT THIS HOUSE, and I WILL, as well as ARMOURBITE, ARMOURSTORM, ARMOUR FLEECE, and ARMOUR BRA trademarks. The company sells its products through wholesale channels, including national and regional sporting goods chains, independent and specialty retailers, department store chains, institutional athletic departments, and leagues and teams, as well as independent distributors; and directly to consumers through a network of brand and factory house stores, and Website. Under Armour, Inc. was founded in 1996 and is headquartered in Baltimore, Maryland.

VCA Inc. (WOOF) opening the day at $90.95. The company has seen its stock increase in value by 32.41% so far this year. The stock was down close to -0.05% on active volume in last trading session and closed at $90.9 per share. After the recent fall, the stock is currently holding -0.74% below its 52 week high of $91.58 and 106.59% above its 12-month low of $44.85. The shares are up by over 31.76% in the last three months, and the RSI indicator value of 91.64 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates in two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services for companion animals, as well as specialized treatments comprising diagnostic, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology services; and sells related retail and pharmaceutical products. It also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. In addition, this segment performs various pet wellness programs, such as health examinations, diagnostic testing, routine vaccinations, spaying, neutering, and dental care. As of December 31, 2015, it operated or managed 682 animal hospitals. The Laboratory segment offers testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment, and prevention of diseases and other conditions affecting animals. This segment serves animal hospitals, animal practices, universities, and other government organizations. It operated a network of 60 laboratories. VCA Inc. also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market, as well as provides education and training, consulting, and mobile imaging services; and franchises pet services, including dog day care, overnight boarding, grooming, and other ancillary services at pet care facilities. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.

 

Stocks To Watch: Denbury Resources Inc. (DNR), Novavax, Inc. (NVAX), American Eagle Outfitters, Inc. (AEO)

Denbury Resources Inc. (DNR) traded within a range of $3.68 to $3.79 after opening the day at $3.75. The company has seen its stock increase in value by 0.82% so far this year. The stock was down close to -0.8% on light volume in last trading session and closed at $3.71 per share. After the recent fall, the stock is currently holding -22.71% below its 52 week high of $4.8 and 331.4% above its 12-month low of $0.89. The shares are up by over 33.94% in the last three months, and the RSI indicator value of 51.31 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Denbury Resources Inc. operates as an independent oil and natural gas company in the United States. The company primarily focuses on enhanced oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. As of December 31, 2015, the company had 288.6 million barrels of oil equivalent of estimated proved oil and natural gas reserves. Denbury Resources Inc. was founded in 1951 and is headquartered in Plano, Texas.

Novavax, Inc. (NVAX) failed to extend gains with the stock declining -3.52% or $-0.05 to close the day at $1.37 on light trading volume of 3.8M shares, compared to its three month average trading volume of 7.97M. The Gaithersburg Maryland 20878 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -77.9%, compared to the industry which has advanced 1.71% over the same period. With RSI of 50.53, the stock should still continue to rise and get closer to its one year target estimate of $3.29, making it a hold for now.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

American Eagle Outfitters, Inc. (AEO) dropped $-0.42 to close the day at a new closing price of $14.88, a -2.75% decrease in value from its previous closing price that moved the stock 20.02% above its 52 week low of $12.78. A total of 3.74M shares exchanged hands during the day compared with its three month average trading volume of 5.77M. The stock, which fluctuated between $14.79 and $15.38 during the day, currently situated -22.76% below its 52 week high. The stock is down by -8.99% in the past one month and down by -12.55% over the past three months. With a one year target estimate of $18.4 and RSI of 37.59, the stock still has upside potential, making it a hold for now.

American Eagle Outfitters, Inc. operates as a specialty retailer offering on-trend clothing, accessories, and personal care products under the American Eagle Outfitters and Aerie brands. The company provides denim, bottoms, and other apparel, as well as footwear and accessories for men and women; and intimates, including bras, undies, swim, and other products, as well as apparel and personal care products for women. In addition, it offers sports apparel under the Tailgate brand; and menswear products under the Todd Snyder New York brand name. The company operates approximately 1,000 stores in the United States, Canada, Mexico, China, Hong Kong, and the United Kingdom, and ships to 81 countries through its websites. It also offers its merchandise at 151 stores operated by licensees in 22 countries, as well as through its Websites at ae.com, aerie.com, TailgateClothing.com, and ToddSnyder.com. American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.

 

Stocks Trend Analysis: PDL BioPharma, Inc. (PDLI), Nuance Communications, Inc. (NUAN), Archer-Daniels-Midland Company (ADM)

PDL BioPharma, Inc. (PDLI) continued its upward trend with the stock climbing 0.43% or $0.01 to close the day at $2.36 on active trading volume of 2.85M shares, compared to its three month average trading volume of 2.71M. The Incline Village Nevada 89451 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -19.69%, compared to the industry which has advanced 1.71% over the same period. With RSI of 52.73, the stock should still continue to rise and get closer to its one year target estimate of $3.67, making it a hold for now.

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. PDL BioPharma, Inc. has license agreements with various biotechnology and pharmaceutical companies, as well as acquires royalty and other assets. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Nuance Communications, Inc. (NUAN) grew with the stock adding 2.14% or $0.33 to close at $15.77 on light trading volume of 2.85M compared its three months average trading volume of 2.86M. The Burlington Massachusetts 01803 based company operating under the Application Software industry has been trending down for the last 52 weeks, with the shares price now -13.59% down for the period and up by 5.84% so far this year. With price target of $20.67 and a 17.34% rebound from 52-week low, Nuance Communications, Inc. has plenty of upside potential, making it a hold with a view buy.

Nuance Communications, Inc. provides voice recognition and natural language understanding solutions worldwide. It operates through four segments: Healthcare, Mobile, Enterprise, and Imaging. The Healthcare segment offers transcription solutions, which enables physicians to streamline clinical documentation with medical transcription platform; Dragon Medical, a dictation software that empowers physicians to accurately capture and document patient care in real-time on various devices; clinical document improvement and coding solutions to ensure patient health information is accurately documented, coded, and evaluated; and diagnostic solutions that allows radiologists to document, collaborate, and share medical images and reports. It also provides Dragon professional and personal productivity solutions to business users and consumers. The Mobile segment provides a portfolio of virtual assistants and connected services built on voice recognition, text-to-speech, natural language understanding, dialog, and text input technologies to automotive manufacturers, device makers, and mobile operators. The Enterprise segment offers OnPremise solutions and services, an automated customer service solution comprising speech recognition, voice biometrics, transcription, text-to-speech, and dialog and analytics products; and OnDemand multichannel cloud, a platform that offers enterprises the ability to implement automatic customer service. The Imaging segment provides MFP Scan automation solutions to offer scanning and document management solutions; MFP Print automation solutions to deliver printing and document management solutions; and PDF and OCR software, a technology that enables the capture, creation, and management of document workflows. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.

Archer-Daniels-Midland Company (ADM) failed to extend gains with the stock declining -1% or $-0.45 to close the day at $44.5 on lower than average trading volume of 2.83M shares, compared to its three month average trading volume of 3.42M. The Chicago Illinois 60601 based company has been outperforming the farm products companies by 6.7247% for last three months and its recent gains have offset losses to -2.52% YTD, versus the farm products industry which is down -2.82% for the same period. The RSI of 47.67 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. Its Agricultural Services segment offers agricultural commodities, such as oilseeds, corn, wheat, milo, oats, rice, and barley; and resells those commodities as food and feed ingredients, and raw materials for the agricultural processing industry. The segment is also involved in structured trade finance and the processing of wheat into wheat flour. Its Corn Processing segment offers ingredients used in the food and beverage industry, including sweeteners, starch, syrup, glucose, and dextrose; bio products; alcohol, amino acids, and other food and animal feed ingredients; and ethyl alcohol for industrial use as ethanol or as beverage grade. This segment also offers corn gluten feed and meal, and distillers’ grains; vegetable oil and protein meal; formula feeds, and animal health and nutrition products; and citric acids and glycols for food and industrial products, as well as operates a sugarcane ethanol plant. The company’s Oilseeds Processing segment processes soybeans and soft seeds into vegetable oils and protein meals. It offers ingredients for the food, feed, energy, and industrial products industries; crude vegetable and salad oils; partially refined oils; oilseed protein meals; peanuts, tree nuts, and peanut-derived ingredients; cottonseed flour for the pharmaceutical industry; cotton cellulose pulp for the chemical, paper, and filter markets; and agricultural commodity raw materials. Its Wild Flavors and Specialty Ingredients segment offers natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products, edible beans, and other specialty food and feed ingredients. The company is also involved in futures commission and insurance activities. Archer-Daniels-Midland Company was founded in 1898 and is headquartered in Chicago, Illinois.